Skip to content
All Brands

Baxter Healthcare

20 recalls on record · Last recall: Aug 17, 2026

Read the history in context

Records, not a safety rating.

Recall counts do not account for sales volume, exposure or differences in reporting. Agency records can overlap. A low count does not establish that a brand or product is safe.

View source coverage →

Severity Breakdown

Class I — Serious
3
Class II — Moderate
17
Class III — Low Risk
0

Categories

MEDICATION

Recall Timeline

Class IFDAAug 17, 2026

Baxter Healthcare — Presence of particulate matter: Particulates identified as fiberglass

0.9% Sodium Chloride Injection USP 500 mL, VIAFLEX Plastic Containers, with 24 units per case. Baxter Healthcare Corporation, Deerfield, IL, 60015, USA, Made in USA, NDC 0338-0049-03 Presence of particulate matter: Particulates identified as fiberglass

Class IFDAAug 17, 2026

Baxter Healthcare — Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution.

Dextrose Injection, USP, 70 %, 2000 mL bags, Rx Only, Baxter Healthcare Corporation Deerfield, IL, 60016, Made in USA, NDC 00338-0719-06 Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution.

Class IIFDAAug 6, 2026

Baxter Healthcare — CGMP Deviations

Clindamycin Injection USP in 5% Dextrose, 900 mg per 50 mL (12 mg/mL) in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-3814-50. CGMP Deviations

Class IIFDAAug 6, 2026

Baxter Healthcare — CGMP Deviations

Vasopressin, in 0.9% Sodium Chloride Injection, 20 units per 100 mL (0.2 units/mL), 100mL Single-Dose Container, Rx only, Sterile, Baxter Healthcare Corporation, Deerfield, IL, 60012 USA, NDC 0338-9640-12. CGMP Deviations

Class IIFDAAug 6, 2026

Baxter Healthcare — CGMP Deviations

Daptomycin, in 0.9% Sodium Chloride Injection, 1,000 mg per 100 mL (10 mg/mL), 1,000 mg total, in 1000 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0718-12. CGMP Deviations

Class IIFDAAug 6, 2026

Baxter Healthcare — CGMP Deviations

CARDENE IV (Nicardipine Hydrochloride) in 0.83% Sodium Chloride Injection, 40 mg in 200 mL (0.2 mg/mL) in GALAXY Single-Dose Container, Manufactured and Marketed by: Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 43066-016-10. CGMP Deviations

Class IIFDAAug 6, 2026

Baxter Healthcare — CGMP Deviations

Pantoprazole Sodium in 0.9% Sodium Chloride Injection, 80 mg/100 mL (0.8 mg/mL) Single-Dose Infusion Bag in 100 mL GALAXY Container, Rx only, Sterile, Baxter Healthcare Corporation, Deerfield, IL, 60015, USA, NDC 0338-9648-12. CGMP Deviations

Class IIFDAAug 6, 2026

Baxter Healthcare — CGMP Deviations

Daptomycin, in 0.9% Sodium Chloride Injection, 500 mg per 50 mL (10 mg/mL), 500 mg total, in 50 mL Single Dose Container (24 bags/carton), Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0714-24. CGMP Deviations

Class IIFDAAug 6, 2026

Baxter Healthcare — CGMP Deviations

Nexterone (amiodarone HCI), 360 mg/200 mL (1.8 mg/mL) in GALAXY Single-Dose Container, sterile, Nonpyrogenic, iso-osmotic solution in Dextrose, Baxter Healthcare Corporation, Deerfield, IL 60015, Made in the USA, NDC 43066-360-20. CGMP Deviations

Class IIFDAAug 6, 2026

Baxter Healthcare — CGMP Deviations

Clindamycin Injection USP in 5% Dextrose, 600 mg per 50 mL (12 mg/mL) in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Baxter healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-3612-50. CGMP Deviations

Class IIFDAAug 6, 2026

Baxter Healthcare — CGMP Deviations

Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection, 400 mcg per 100 mL (4 mcg/mL) in Galaxy 100 mL Single Dose Container, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-9557-12. CGMP Deviations

Class IIFDAAug 6, 2026

Baxter Healthcare — CGMP Deviations

Clindamycin Injection USP in 5% Dextrose, 900 mg/50 mL (18 mg/mL), in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Manufactured by: Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-4114-50. CGMP Deviations

Class IIFDAAug 6, 2026

Baxter Healthcare — CGMP Deviations

MYXREDLIN, Insulin Human in 0.9% Sodium Chloride Injection, 100 units/100 mL (1 unit/mL), Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0126-12. CGMP Deviations

Class IIFDAAug 6, 2026

Baxter Healthcare — CGMP Deviations

Famotidine Injection in Sodium Chloride Injection, 20 mg, 50 mL in GALAXY Single Dose Container, Rx Only, Sterile Nonpyrogenic, Baxter International Inc., Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-5197-41. CGMP Deviations

Class IIFDAAug 6, 2026

Baxter Healthcare — CGMP Deviations

Vancomycin Injection, USP, in 0.9% Sodium Chloride, 1g per 200 mL (5 mg/mL) in GALAXY Single-Dose Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL, 60015 USA, NDC 0338-3583-01. CGMP Deviations

Class IIFDAAug 6, 2026

Baxter Healthcare — CGMP Deviations

Vasopressin, in 0.9% Sodium Chloride Injection, 40 units per 100 mL (0.4 units/mL), 100mL Single-Dose Container, Rx only, Sterile, Baxter Healthcare Corporation, Deerfield, IL, 60015 USA, NDC 0338-9647-12. CGMP Deviations

Class IIFDAAug 6, 2026

Baxter Healthcare — CGMP Deviations

Clindamycin Injection USP in 5% Dextrose, 900 mg/50 mL (18 mg/mL), in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Manufactured by: Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 43066-995-24. CGMP Deviations

Class IIFDAAug 6, 2026

Baxter Healthcare — CGMP Deviations

Vancomycin Injection, USP in 5% Dextrose, 1 g per 200mL (5 mg/mL), in GALAXY Single-Dose Container, Rx only, Sterile Nonpyrogenic, Iso-osmotic, Baxter Healthcare Corporation, Deerfield, IL, 60015 USA, NDC 0338-3552-48. CGMP Deviations

Class IIFDAAug 6, 2026

Baxter Healthcare — CGMP Deviations

Clindamycin Phosphate in 0.9% Sodium Chloride Injection, 600 mg per 50 mL (12 mg/mL), 50 mL Single-Dose GALAXY Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-9549-50. CGMP Deviations

Class IFDAJul 24, 2026

Baxter Healthcare — Presence of Particulate Matter

Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container, Frozen Premix, Sterile, Rx only, Manufactured by Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-3508-41. Presence of Particulate Matter

Track Baxter Healthcare recalls automatically

Get an alert when a matching Baxter Healthcare recall turns up.

Start Free Trial